Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP368379.RAOFMv899Yc-Ib5yPKRb_wdDPokiNBrhEBEC2nxuJW2_Y130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP368379.RAOFMv899Yc-Ib5yPKRb_wdDPokiNBrhEBEC2nxuJW2_Y130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP368379.RAOFMv899Yc-Ib5yPKRb_wdDPokiNBrhEBEC2nxuJW2_Y130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP368379.RAOFMv899Yc-Ib5yPKRb_wdDPokiNBrhEBEC2nxuJW2_Y130_provenance.
- NP368379.RAOFMv899Yc-Ib5yPKRb_wdDPokiNBrhEBEC2nxuJW2_Y130_assertion description "[The EGFR antibody cetuximab is used to treat numerous cancers, but intrinsic and acquired resistance to this agent is a common clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP368379.RAOFMv899Yc-Ib5yPKRb_wdDPokiNBrhEBEC2nxuJW2_Y130_provenance.
- NP368379.RAOFMv899Yc-Ib5yPKRb_wdDPokiNBrhEBEC2nxuJW2_Y130_assertion evidence source_evidence_literature NP368379.RAOFMv899Yc-Ib5yPKRb_wdDPokiNBrhEBEC2nxuJW2_Y130_provenance.
- NP368379.RAOFMv899Yc-Ib5yPKRb_wdDPokiNBrhEBEC2nxuJW2_Y130_assertion SIO_000772 25136066 NP368379.RAOFMv899Yc-Ib5yPKRb_wdDPokiNBrhEBEC2nxuJW2_Y130_provenance.
- NP368379.RAOFMv899Yc-Ib5yPKRb_wdDPokiNBrhEBEC2nxuJW2_Y130_assertion wasDerivedFrom befree-20150227 NP368379.RAOFMv899Yc-Ib5yPKRb_wdDPokiNBrhEBEC2nxuJW2_Y130_provenance.
- NP368379.RAOFMv899Yc-Ib5yPKRb_wdDPokiNBrhEBEC2nxuJW2_Y130_assertion wasGeneratedBy ECO_0000203 NP368379.RAOFMv899Yc-Ib5yPKRb_wdDPokiNBrhEBEC2nxuJW2_Y130_provenance.
- befree-20150227 importedOn "2015-02-27" NP368379.RAOFMv899Yc-Ib5yPKRb_wdDPokiNBrhEBEC2nxuJW2_Y130_provenance.